Skip to main
BIOX
BIOX logo

BIOX Stock Forecast & Price Target

BIOX Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Bioceres Crop Solutions demonstrates a positive outlook through its resilient Crop Protection portfolio, which, despite losing some market share in Argentina, is well-positioned to capitalize on a potential recovery in local farmer demand. The company is also benefiting from robust international opportunities, particularly with its HB4 wheat technology, which is expected to generate significant revenue in key markets such as the US, Brazil, and Australia. Additionally, sustained growth in bio-protection products and adjuvant sales outside of Argentina has helped offset weaker domestic performance, further supporting the company's overall financial health.

Bears say

Bioceres Crop Solutions Corp has experienced a significant decline in its top line, primarily driven by weaker demand for its Crop Protection and Crop Nutrition solutions in Argentina, alongside decreased revenue from the HB4-related sales following a strategic shift to a licensing-based business model. The company’s Crop Nutrition segment reported a notable year-over-year decline of approximately 34%, totaling around $25 million, attributed to softer market demand and pricing pressures exacerbated by reduced corn acreage. Additionally, revenues from Seed & Integrated products plummeted nearly 75% year-over-year to approximately $8 million, reflecting the company's transition away from seed production and sales as part of its new business strategy.

BIOX has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Bioceres Crop Solutions Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Bioceres Crop Solutions Corp (BIOX) Forecast

Analysts have given BIOX a Buy based on their latest research and market trends.

According to 3 analysts, BIOX has a Buy consensus rating as of Nov 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Bioceres Crop Solutions Corp (BIOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.